• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

ACTRIMS Forum 2025 highlights – Focus on ofatumumab

March 10, 2025  

ACTRIMS Forum 2025 Highlights – Saturday, March 1, 2025

March 1, 2025  

ACTRIMS Forum 2025 Highlights – Friday, February 28, 2025

February 28, 2025  

CLINICAL CASES IN MS: A 38-YEAR-OLD WOMAN PLANNING PREGNANCY

February 27, 2025  

sNfL useful in prognosis for first demyelinating event

February 20, 2025  

Switching from natalizumab to anti-CD20 agents

January 28, 2025  

Fluid biomarkers during B cell-depleting therapy

January 17, 2025  

High-efficacy DMTs in MS – the year in review

November 14, 2024  

Pregnancy and MS – new data from ECTRIMS

October 17, 2024  

ECTRIMS update on ofatumumab

October 11, 2024  
Previous
1
2
3
4
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions